Frontzek, Fabian https://orcid.org/0000-0003-1705-3638
Renaud, Loïc https://orcid.org/0000-0001-7213-9464
Dührsen, Ulrich
Poeschel, Viola
Bernard, Sophie
Chartier, Loïc
Ketterer, Nicolas
Récher, Christian
Fitoussi, Olivier
Held, Gerhard
Casasnovas, Olivier https://orcid.org/0000-0002-1156-8983
Haioun, Corinne
Mounier, Nicolas
Tilly, Hervé
Morschhauser, Franck https://orcid.org/0000-0002-3714-9824
Le Gouill, Steven
Karsten, Imke E.
Duns, Gerben
Steidl, Christian https://orcid.org/0000-0001-9842-9750
Scott, David W.
Klapper, Wolfram https://orcid.org/0000-0001-7208-4117
Rosenwald, Andreas
Ott, German
Molina, Thierry https://orcid.org/0000-0002-3929-9754
Lenz, Georg
Ziepert, Marita
Altmann, Bettina
Thieblemont, Catherine
Schmitz, Norbert https://orcid.org/0000-0003-4938-7528
Article History
Received: 3 April 2024
Revised: 25 July 2024
Accepted: 31 July 2024
First Online: 16 August 2024
Competing interests
: Fabian Frontzek: F.F. is the recipient of a scholarship from the Deutsche Forschungs-gemeinschaft (DFG). Loic Renaud: Astra Zeneca, Janssen, Takeda; Travel fees: Kite/ Gilead. Georg Lenz: G.L. received research grants not related to this manuscript from AGIOS, AQUINOX, AstraZeneca, Bayer, Celgene, Gilead, Janssen, Morphosys, Novartis, Roche, and Verastem. G.L. received honoraria from ADC Therapeutics, Abbvie, Amgen, AstraZeneca, Bayer, BMS, Celgene, Constellation, Genase, Genmab, Gilead, Hexal/Sandoz, Immagene, Incyte, Janssen, Karyopharm, Lilly, Miltenyi, Morphosys, MSD, NanoString, Novartis, PentixaPharm, Roche, and Sobi. Catherine Thieblemont: Honorarium /board: Roche, Incyte, Kyte/Gilead, Novartis, AstraZeneca, Takeda. Norbert Schmitz: Honoraria: Roche; Travel grants: Beigene; Stock: BMS; Research grants: Janssen. All other authors: None.
: Study protocols were approved by sites’ institutional review boards and/or ethics committees. All patients gave written informed consent. This study was performed in accordance with the declaration of Helsinki and the guidelines of Good Clinical Practice.